Landogrozumab (anti-GDF8)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Lifastuzumab vedotin (anti-SLC34A2)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Lilotomab (anti-TSPAN26)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Lintuzumab (anti-CD33)
229.00 ¥ 229.00 ¥ 229.0 CNY
Livmoniplimab (anti-LRRC32/TGFβ1)
119.00 ¥ 119.00 ¥ 119.0 CNY
Lorvotuzumab mertansine (anti-NCAM1)
509.00 ¥ 509.00 ¥ 509.0 CNY
Lutikizumab (anti-IL1a&IL1b)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
LY3022855 (anti-CSF1R)
139.00 ¥ 139.00 ¥ 139.0 CNY
Mezagitamab (anti-CD38)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Mosunetuzumab (anti-CD20&CD3e)
139.00 ¥ 139.00 ¥ 139.0 CNY
Namilumab (anti-GM-CSF)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Natalizumab (anti-ITGA4)
109.00 ¥ 109.00 ¥ 109.0 CNY
Otilimab (anti-GM-CSF)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Ozoralizumab (anti-TNF-alpha&HSA)
159.00 ¥ 159.00 ¥ 159.0 CNY
Pascolizumab (anti-IL-4)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Polatuzumab vedotin-piiq (anti-CD79b)
509.00 ¥ 509.00 ¥ 509.0 CNY
Quilizumab (anti-IgE)
199.00 ¥ 199.00 ¥ 199.0 CNY
Rovelizumab (anti-CD11a&CD18)
139.00 ¥ 139.00 ¥ 139.0 CNY
Sacituzumab govitecan (anti-TROP2)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Satralizumab (anti-IL-6Ra)
99.00 ¥ 99.00 ¥ 99.0 CNY